Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Change in Inventory (2016)

Historic Change in Inventory for Viridian Therapeutics, Inc.\DE (VRDN) over the last 3 years, with Q4 2016 value amounting to $2000.0.

  • Viridian Therapeutics, Inc.\DE's Change in Inventory rose 10112.99% to $2000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was -$123000.0, marking a year-over-year decrease of 163750.0%. This contributed to the annual value of -$123000.0 for FY2016, which is 163750.0% down from last year.
  • Viridian Therapeutics, Inc.\DE's Change in Inventory amounted to $2000.0 in Q4 2016, which was up 10112.99% from -$151000.0 recorded in Q3 2016.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Change in Inventory registered a high of $206000.0 during Q2 2015, and its lowest value of -$232000.0 during Q1 2014.
  • Over the past 3 years, Viridian Therapeutics, Inc.\DE's median Change in Inventory value was -$25500.0 (recorded in 2014), while the average stood at -$24416.7.
  • The largest annual percentage gain for Viridian Therapeutics, Inc.\DE's Change in Inventory in the last 5 years was 20294.12% (2015), contrasted with its biggest fall of 54102.56% (2015).
  • Viridian Therapeutics, Inc.\DE's Change in Inventory (Quarter) stood at -$53000.0 in 2014, then tumbled by 233.96% to -$177000.0 in 2015, then surged by 101.13% to $2000.0 in 2016.
  • Its last three reported values are $2000.0 in Q4 2016, -$151000.0 for Q3 2016, and -$56000.0 during Q2 2016.